Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Results>CSPC PHARMA 1Q Underlying Profit Falls 40.3% YoY to RMB842M
Recommend 5 Positive 7 Negative 7 |
||||
|
||||
|
CSPC PHARMA (01093.HK) announced its results for 1Q26 ended March. Revenue amounted to RMB6.465 billion, down 7.8% YoY. Net profit was RMB860 million, down 41.8% YoY; EPS was RMB7.54 cents. During the period, excluding fair value changes on financial assets measured at FVTPL and employee share-based compensation expenses, the underlying profit attributable to shareholders of the Company amounted to RMB842 million, down 40.3% YoY. Auto-translated by AI This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
